Severe Anemia Due to Parvovirus Infection Following Treatment with Rituximab in a Pediatric Kidney Transplant Recipient : Anemia after Treatment of Rituximab in Kidney Recipient Patient
Rituximab (RTX), a monoclonal antibody against the B-cell marker CD20, is commonly used as a treatment for antibody-mediated diseases or B-lymphocyte-mediated diseases. Destruction of B cells may reverse the disease course in many conditions; however, patients who are treated with RTX cannot respond...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Society of Pediatric Nephrology
2015-10-01
|
| シリーズ: | Childhood Kidney Diseases |
| 主題: | |
| オンライン･アクセス: | http://www.chikd.org/upload/ckd-19-2-176.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|